Skip to main content

Table 2 Schedule of study activities

From: Design and methodology of the SARCopenia trajectories and associations with adverse clinical outcomes in patients on HemoDialysis: the SARC-HD study

Measure

Screening

Baseline

12 months

24 months

Informed consent form

x

   

Eligibility criteria screen

x(a)

   

Sociodemographics

x(a)

   

Medical history

x

   

International Physical Activity Questionnaire

 

x(b)

  

Mini-Mental State Exam

 

x(b)

  

7-point subjective global assessment

 

x(b)

x(b)

 

SARC-F and SARC-CalF

 

x(b)

x(b)

 

Primary outcomes

 Handgrip strength

 

x(c)

x(c)

 

 Five-time sit-to-stand test

 

x(c)

x(c)

 

 4-m gait speed

 

x(c)

x(c)

 

 Muscle mass

 

x(d)

x(d)

 

Secondary outcomes

 Falls

  

x

x

 Hospitalization

  

x

x

 Mortality

  

x

x

  1. aAfter signing the informed consent form
  2. bThe application of questionnaires will be conducted during hemodialysis session
  3. cAssessment of physical function will be conducted before hemodialysis and the mid-week session
  4. dAssessment of body composition will be conducted after hemodialysis and the mid-week session